All the sessions from Transform 2021 are available on-demand now. Watch now.
San Francisco’s DecisionView, which sells software that helps biotech and pharmaceutical companies run clinical trials more efficiently, raised $9 million in a third round of funding. The round was led by firstVentury, a new investor joined by Partech International and Granite Ventures.
From the company’s release:
The funding will be used to scale its commercial growth capabilities and expand DecisionView’s suite of clinical performance optimization applications, including the company’s innovative clinical recruitment platform, StudyOptimizer™. As the industry’s first business performance optimization application for clinical trials, StudyOptimizer automates the recruitment process with integrated predictive modeling, simulation, planning, and rich visualization capabilities. The company was also recently named in the list of “Cool Vendors” in the “Cool Vendors in Life Sciences, 2007” report by Gartner, Inc.
VentureBeatVentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
- up-to-date information on the subjects of interest to you
- our newsletters
- gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
- networking features, and more